Trials / Active Not Recruiting
Active Not RecruitingNCT04433858
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Sheppard Pratt Health System · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the efficacy of psilocybin (25 mg) administered under supportive conditions to adult participants with severe TRD, in improving depressive symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Psilocybin | open-label |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2025-06-01
- Completion
- 2026-05-01
- First posted
- 2020-06-16
- Last updated
- 2024-08-09
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04433858. Inclusion in this directory is not an endorsement.